- Report
- October 2022
- 163 Pages
Global
From €3140EUR$3,600USD£2,735GBP
- Report
- October 2022
- 75 Pages
Asia Pacific
From €1308EUR$1,500USD£1,140GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
Japan
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
Japan
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
China
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
China
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- March 2024
Global
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- January 2025
Latin America
From €7414EUR$8,500USD£6,457GBP
- Report
- January 2025
Australia
From €829EUR$950USD£722GBP
From €2181EUR$2,500USD£1,899GBP
- Report
- May 2024
Saudi Arabia
From €2181EUR$2,500USD£1,899GBP
- Report
- May 2024
Australia
From €2181EUR$2,500USD£1,899GBP
From €2181EUR$2,500USD£1,899GBP
- Report
- May 2024
Germany
From €3053EUR$3,500USD£2,659GBP
- Report
- May 2024
United Kingdom
From €3053EUR$3,500USD£2,659GBP
From €3053EUR$3,500USD£2,659GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more